Quince Therapeutics, Inc. (QNCX) Live Share Price, Invest From India

Quince Therapeutics, Inc. Stock Performance

as on June 13, 2026 at 2:15 pm IST

Day's Low
Day's High
$0.92
Day's Price Range
$1.00
$0.93
1.08%
Downside
7.53%
Upside
52 Week's Low
52 Week's High
$0.79
52-Week Price Range
$45.50
$0.93
15.05%
Downside
4792.37%
Upside

Quince Therapeutics, Inc. share price movements today

Previous Close: $0.95
Open: $0.95
Volume: 643.2K
Day's Low - High: $0.92 - $1.00
52 Week Low - High: $0.79 - $45.50

Quince Therapeutics, Inc. Historical Returns

1 Month Return: -24.84 %
3 Month Return: -11.08 %
1 Year Return: -92.11 %
3 Year Return: -94.08 %
5 Year Return: 0 %

Quince Therapeutics, Inc. Stock Fundamentals & Key Indicators

Check Quince Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$17.8M

EPS (TTM)

-11.7

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-48.5M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-192.90%

Quince Therapeutics, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Quince Therapeutics, Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Quince Therapeutics, Inc.	SELL	$17.8M	NA	NA	0.00%	NA
Alnylam Pharmaceuticals Inc	BUY	$39.7B	75.37%	74.61	12.55%	NA
Vertex Pharmaceuticals Inc	BUY	$113.1B	130.57%	26.46	35.51%	NA
Regeneron Pharmaceuticals Inc	BUY	$64.6B	16.35%	15.04	29.65%	0.59%

Stock Returns calculator for Quince Therapeutics, Inc. Stock including INR - Dollar returns

The Quince Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Quince Therapeutics, Inc. investment value today

Current value as on today

₹8,559

Returns

-₹91,441

(-91.44%)

Returns from Quince Therapeutics, Inc. Stock

-₹92,250 (-92.25%)

Dollar Impact

₹809 (+0.81%)

Analyst Recommendation on Quince Therapeutics, Inc. Stock

Based on 6 analysts

SELL

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 6 analysts, 50% of analysts recommend a 'SELL' rating for Quince Therapeutics, Inc.. Average target price of $5

Quince Therapeutics, Inc. Share Price Target

Get share price movements and forecasts by analysts on Quince Therapeutics, Inc..

What analysts predicted

81.4%UPSIDE

Target Price

Current Price

$0.93

Analyzed by

6 Analysts

Target

$5.00

Quince Therapeutics, Inc. target price $5, a slight upside of 81.4% compared to current price of $0.93. According to 6 analysts rating.

Indian Investors' Interest in Quince Therapeutics, Inc. Stock

Search interest for Quince Therapeutics, Inc. Stock has decreased by -70% in the last 30 days, reflecting a downward trend in search activity.

Time period: May 15, 2026 to June 14, 2026

Change:-70% versus previous 30 day period

Quince Therapeutics, Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	-	0	-	-	0	-	-	-	-	-
Gross Profit	-	0	0	0	0	0	0	0	-	0
Operating Income	-8	-11	-28	-5	-10	-14	-9	-13	-16	-11
EBITDA	-	-8	-8	-8	-12	-12	-15	-11	-	-11
Interest Expense	-	0	-	-	2	-	-	-	-	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-8	-11	-27	-5	-12	-14	-15	-13	-36	30
Income Tax Expense	-	0	0	0	0	0	0	0	-	-5
Net Income	-8	-11	-27	-5	-12	-15	-16	-13	-39	35
Net Profit Margin	0.00%	-30969.44%	0.00%	0.00%	-7415.48%	0.00%	0.00%	0.00%	0.00%	0.00%

Quince Therapeutics, Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	0
Operating Income	-12	-39	-78	-90	-52	-34	-57	-50
EBITDA	-12	-38	-78	-89	-50	-26	-35	-50
Interest Expense	0	2	2	0	0	-	-	-
Depreciation	0	0	0	0	0	0	0	0
Income Before Tax	-12	-36	-76	-89	-51	-31	-56	-80
Income Tax Expense	0	0	2	0	0	0	0	3
Net Income	-12	-36	-76	-89	-51	-31	-56	-83
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Quince Therapeutics, Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-11	-27	-5	-12	-15	-16	-13	-39	35
Operating Cash Flow	-8	-8	-7	-7	-9	-11	-9	-10	-7
Investing Cash Flow	8	-4	7	10	10	6	-1	-	12
Financing Cash Flow	0	0	-5	-	0	14	1	2	9
Change in Cash	1	-13	-5	3	1	9	-10	0	12

Quince Therapeutics, Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-12	-36	-76	-89	-51	-31	-56	-83
Operating Cash Flow	-11	-33	-50	-62	-44	-18	-31	-41
Investing Cash Flow	-46	-17	-52	58	18	-5	21	23
Financing Cash Flow	75	77	118	6	0	0	-4	17
Change in Cash	17	26	15	2	-25	-23	-14	0

Global Institutional Holdings in Quince Therapeutics, Inc.

Funds	Holdings
JustInvest LLC	0.07%
Shay Capital LLC	0.91%
StemPoint Capital LP	0.45%
Nantahala Capital Management, LLC	1.64%
Almitas Capital LLC	0.48%

See all

Insights on Quince Therapeutics, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Quince Therapeutics, Inc. Common Stock has experienced a drawdown of -93.9%, however Alnylam Pharmaceuticals, Inc. Common Stock resisted the overall trend and outperformed by 73.2%
NO EFFECT
Against Peers
In the last 1 year, Regeneron Pharmaceuticals, Inc. Common Stock has given 15.5% return, outperforming this stock by 108.9%
NEGATIVE IMPACT
Price Dip
In the last 7 days, QNCX stock has moved down by -6.2%

About Quince Therapeutics, Inc.

Quince Therapeutics, Inc., a biotechnology company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. The company's lead asset candidature comprises eDSP, which is in Phase 3, for the treatment of rare pediatric neurodegenerative disease, including A-T, an inherited autosomal recessive neurodegenerative and immunodeficiency disorder caused by mutations in ATM gene. Its AIDE technology platform, a drug/device combination platform that uses an automated process to encapsulate a drug into a patient's own red blood cells, as well as consist of an automated equipment the RCL, a sterile single-use consumable treatment kit comprising kit medical devices, syringe kit, and process solutions. The company was formerly known as Cortexyme, Inc. and changed its name to Quince Therapeutics, Inc. in August 2022. The company was incorporated in 2012 and is headquartered in South San Francisco, California.

Organisation	Quince Therapeutics, Inc.
Headquarters	611 Gateway Boulevard, South San Francisco, CA, United States, 94080
Industry	Biotechnology
CEO	Dr. Dirk Thye M.D.
E-voting on shares	Click here to vote

Key Management of Quince Therapeutics, Inc.

Name	Title
Dr. Dirk Thye M.D.	CEO, Chief Medical Officer & Director
Dr. Charles S. Ryan J.D., Ph.D.	President
Mr. Brendan Hannah M.B.A.	Chief Business Officer, COO, Chief Compliance Officer and Principal Financial & Accounting Officer
Mr. Giovanni Mambrini M.Sc.	Chief Technology Officer
Dr. Guenter R. Janhofer M.D., Ph.D.	Chief Scientific Officer
Dr. Brigette Roberts M.D.	Chief Corporate Affairs Officer & Director

FAQs

What is Quince Therapeutics, Inc. share price today?

Quince Therapeutics, Inc. share price today is $0.93 as on June 13, 2026 at 8:45 am IST at the close of the market. Quince Therapeutics, Inc. share today touched a day high of $1 and a low of $0.92.

What is the 52 week high and 52 week low for Quince Therapeutics, Inc. share?

Quince Therapeutics, Inc. share touched a 52 week high of $45.5 on December 12, 2025 and a 52 week low of $0.79 on May 18, 2026. Quince Therapeutics, Inc. stock price today i.e. June 13, 2026 at 8:45 am IST is closed at $0.93,which is 97.96% down from its 52 week high and 17.72% up from its 52 week low.

What is Quince Therapeutics, Inc.'s market capitalisation today?

Quince Therapeutics, Inc. market capitalisation is $0.00T as on June 13, 2026 at 8:45 am IST.

How to invest in Quince Therapeutics, Inc. Stock (QNCX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Quince Therapeutics, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Quince Therapeutics, Inc. Shares that will get you 1.6129 shares as per Quince Therapeutics, Inc. share price of $0.93 per share as on June 13, 2026 at 8:45 am IST.

What is the minimum amount required to buy Quince Therapeutics, Inc. Stock (QNCX) from India?

Indian investors can start investing in Quince Therapeutics, Inc. (QNCX) shares with as little as ₹95.1 or $1 (as of June 14, 2026 at 6:24 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹951.00 in Quince Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on June 14, 2026 at 6:24 pm IST). Based on Quince Therapeutics, Inc. share’s latest price of $0.93 as on June 13, 2026 at 8:45 am IST, you will get 10.7527 shares of Quince Therapeutics, Inc.. Learn more about fractional shares .